众兴菌业2025年中报简析：净利润增134.13%，盈利能力上升

Core Viewpoint - The recent financial report of Zhongxing Junye (002772) shows a mixed performance with a slight decline in total revenue but a significant increase in net profit, indicating improved profitability despite challenges in revenue growth [1]. Financial Performance Summary - Total revenue for the first half of 2025 was 908 million yuan, a decrease of 0.75% year-on-year [1]. - Net profit attributable to shareholders reached 69.02 million yuan, an increase of 134.13% year-on-year [1]. - In Q2 2025, total revenue was 435 million yuan, up 1.69% year-on-year, while net profit was 20.82 million yuan, up 495.21% year-on-year [1]. - Gross margin improved to 19.41%, a year-on-year increase of 9.56%, and net margin rose to 7.5%, up 139.76% year-on-year [1]. - Total expenses (selling, administrative, and financial) amounted to 118 million yuan, accounting for 12.97% of revenue, a decrease of 10.73% year-on-year [1]. Key Financial Ratios - Earnings per share (EPS) increased to 0.18 yuan, a rise of 145.33% year-on-year [1]. - Operating cash flow per share was 0.38 yuan, down 16.76% year-on-year [1]. - The company's return on invested capital (ROIC) was 3.02% last year, indicating generally weak capital returns [1]. - The debt ratio (interest-bearing liabilities) reached 41.53%, highlighting the company's debt situation [2]. Fund Holdings - The largest fund holding Zhongxing Junye is the Manulife Consumer Dividend Index A, with a scale of 576 million yuan and a recent net value increase of 1.14% [3]. - Other funds such as the Caitong Huazhen Quantitative Stock Mixed A have also increased their holdings in the company [2].